dc.contributor.author | BOZKAYA, HAKAN | |
dc.contributor.author | Cakaloglu, Yilmaz | |
dc.contributor.author | Zeuzem, Stefan | |
dc.contributor.author | Dalekos, George N. | |
dc.contributor.author | Manns, Michael P. | |
dc.contributor.author | Wedemeyer, Heiner | |
dc.contributor.author | Yurdaydin, Cihan | |
dc.contributor.author | Zachou, Kalliopi | |
dc.contributor.author | Erhardi, Annette | |
dc.contributor.author | YALÇIN, KENDAL | |
dc.contributor.author | Gurel, Selim | |
dc.date.accessioned | 2021-03-03T09:10:01Z | |
dc.date.available | 2021-03-03T09:10:01Z | |
dc.identifier.citation | Wedemeyer H., Yurdaydin C., Zachou K., Erhardi A., Cakaloglu Y., YALÇIN K., Gurel S., Zeuzem S., BOZKAYA H., Dalekos G. N. , et al., "BASELINE ALT LEVELS BUT NOT HDV-RNA LEVELS ARE ASSOCIATED WITH RESPONSE TO PEGYLATED INTERFERON ALFA-2A TREATMENT OF DELTA HEPATITIS: DATA FROM THE HIDIT-1 TRIAL", 59th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases, San-Francisco, Kostarika, 31 Ekim - 04 Kasım 2008, cilt.48 | |
dc.identifier.other | vv_1032021 | |
dc.identifier.other | av_1b85c8fb-305f-4d1c-99d8-29fea8b45faa | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/23788 | |
dc.language.iso | eng | |
dc.subject | Sağlık Bilimleri | |
dc.subject | Dahili Tıp Bilimleri | |
dc.subject | İç Hastalıkları | |
dc.subject | Gastroenteroloji-(Hepatoloji) | |
dc.subject | Klinik Tıp (MED) | |
dc.subject | Tıp | |
dc.subject | Klinik Tıp | |
dc.subject | GASTROENTEROLOJİ VE HEPATOLOJİ | |
dc.title | BASELINE ALT LEVELS BUT NOT HDV-RNA LEVELS ARE ASSOCIATED WITH RESPONSE TO PEGYLATED INTERFERON ALFA-2A TREATMENT OF DELTA HEPATITIS: DATA FROM THE HIDIT-1 TRIAL | |
dc.type | Bildiri | |
dc.contributor.department | Hannover Medical School , , | |
dc.identifier.volume | 48 | |
dc.contributor.firstauthorID | 135391 | |